Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 84

Similar articles for PubMed (Select 20019701)

1.

Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats.

Sakurada M, Yoshimoto T, Sekizawa N, Hirono Y, Suzuki N, Hirata Y.

Hypertens Res. 2010 Mar;33(3):229-35. doi: 10.1038/hr.2009.211. Epub 2009 Dec 18.

PMID:
20019701
2.

Aldosterone and the cardiovascular system: a dangerous association.

Cachofeiro V, López-Andrés N, Miana M, Martín-Fernández B, de Las Heras N, Martínez E, Lahera V, Fortuño MA.

Horm Mol Biol Clin Investig. 2010 Dec 1;4(2):539-48. doi: 10.1515/HMBCI.2010.057.

PMID:
25961230
3.

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.

Ichikawa D, Kamijo-Ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Hoshino S, Katayama K, Igarashi-Migitaka J, Hirata K, Kimura K.

Am J Physiol Renal Physiol. 2015 Jan 15;308(2):F114-21. doi: 10.1152/ajprenal.00469.2014. Epub 2014 Oct 22.

PMID:
25339700
4.

Suppression of aldosterone and progesterone in preeclampsia.

Uddin MN, Horvat D, Jones RO, Beeram MR, Zawieja DC, Perger L, Sprague DC, Kuehl TJ.

J Matern Fetal Neonatal Med. 2014 Aug 28:1-6. [Epub ahead of print]

PMID:
25164552
5.

Short-term cardiovascular effects of selective phosphodiesterase 3 inhibitor olprinone versus non-selective phosphodiesterase inhibitor aminophylline in a meconium-induced acute lung injury.

Mokra D, Tonhajzerova I, Pistekova H, Visnovcova Z, Mokry J, Drgova A, Repcakova M, Calkovska A.

J Physiol Pharmacol. 2013 Dec;64(6):751-9.

6.
7.

Galectin-3 mediates aldosterone-induced vascular fibrosis.

Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, de Boer RA, Poirier F, Lacolley P, Zannad F, Rossignol P, López-Andrés N.

Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):67-75. doi: 10.1161/ATVBAHA.112.300569. Epub 2012 Nov 1.

8.

Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability.

Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE.

Nitric Oxide. 2012 Mar 31;26(3):162-8. doi: 10.1016/j.niox.2012.01.009. Epub 2012 Feb 3.

9.

Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency.

Nakmareong S, Kukongviriyapan U, Pakdeechote P, Kukongviriyapan V, Kongyingyoes B, Donpunha W, Prachaney P, Phisalaphong C.

Hypertens Res. 2012 Apr;35(4):418-25. doi: 10.1038/hr.2011.180. Epub 2011 Nov 10.

PMID:
22072109
10.

A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.

López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2372-82. doi: 10.1152/ajpheart.00283.2011. Epub 2011 Sep 16.

11.

Simvastatin enhances the antihypertensive effect of ramipril in hypertensive hypercholesterolemic animals and patients. Possible role of nitric oxide, oxidative stress, and high sensitivity C-reactive protein.

Abdel-Zaher AO, Elkoussi AE, Abudahab LH, Elbakry MH, Elsayed EA.

Fundam Clin Pharmacol. 2012 Dec;26(6):701-11. doi: 10.1111/j.1472-8206.2011.00975.x. Epub 2011 Sep 13.

PMID:
21913974
12.

Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.

Gómez-Guzmán M, Jiménez R, Sánchez M, Romero M, O'Valle F, Lopez-Sepulveda R, Quintela AM, Galindo P, Zarzuelo MJ, Bailón E, Delpón E, Perez-Vizcaino F, Duarte J.

Br J Nutr. 2011 Nov;106(9):1337-48. doi: 10.1017/S0007114511004314. Epub 2011 Sep 13.

PMID:
21910946
13.

Betulinic acid ameliorates endothelium-dependent relaxation in L-NAME-induced hypertensive rats by reducing oxidative stress.

Fu JY, Qian LB, Zhu LG, Liang HT, Tan YN, Lu HT, Lu JF, Wang HP, Xia Q.

Eur J Pharm Sci. 2011 Oct 9;44(3):385-91. doi: 10.1016/j.ejps.2011.08.025. Epub 2011 Sep 1.

PMID:
21907795
14.

Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.

Bhatia J, Tabassum F, Sharma AK, Bharti S, Golechha M, Joshi S, Sayeed Akhatar M, Srivastava AK, Arya DS.

Cardiovasc Toxicol. 2011 Sep;11(3):272-9. doi: 10.1007/s12012-011-9122-2.

PMID:
21748534
15.

Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathways.

Newfell BG, Iyer LK, Mohammad NN, McGraw AP, Ehsan A, Rosano G, Huang PL, Mendelsohn ME, Jaffe IZ.

Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1871-80. doi: 10.1161/ATVBAHA.111.229070. Epub 2011 May 26.

16.

Study of the mechanisms of aldosterone prothrombotic effect in rats.

Gromotowicz A, Szemraj J, Stankiewicz A, Zakrzeska A, Mantur M, Jaroszewicz E, Rogowski F, Chabielska E.

J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):430-9. doi: 10.1177/1470320310397405. Epub 2011 Mar 18.

PMID:
21421657
17.

Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.

Zhang Q, Huang JH, Xia RP, Duan XH, Jiang YB, Jiang Q, Sun WJ.

J Surg Res. 2011 May 15;167(2):e385-93. doi: 10.1016/j.jss.2011.01.017. Epub 2011 Feb 24.

PMID:
21392796
18.

Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Ebrahimian T, Li MW, Lemarié CA, Simeone SM, Pagano PJ, Gaestel M, Paradis P, Wassmann S, Schiffrin EL.

Hypertension. 2011 Feb;57(2):245-54. doi: 10.1161/HYPERTENSIONAHA.110.159889. Epub 2010 Dec 20.

19.

Effect of lignin-derived lignophenols on vascular oxidative stress and inflammation in streptozotocin-induced diabetic rats.

Mukai Y, Norikura T, Fujita S, Mikame K, Funaoka M, Sato S.

Mol Cell Biochem. 2011 Feb;348(1-2):117-24. doi: 10.1007/s11010-010-0645-9. Epub 2010 Nov 10.

PMID:
21063899
20.

Structural, functional, and molecular alterations produced by aldosterone plus salt in rat heart: association with enhanced serum and glucocorticoid-regulated kinase-1 expression.

Martín-Fernández B, de las Heras N, Miana M, Ballesteros S, Delgado C, Song S, Hintze T, Cachofeiro V, Lahera V.

J Cardiovasc Pharmacol. 2011 Jan;57(1):114-21. doi: 10.1097/FJC.0b013e31820088ca.

PMID:
20980916
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk